On ECHEMI
Home > Drugs > Felodipine Tablets

Felodipine Tablets

Function and Efficacy

When taking this product, taking drugs that affect cytochrome P450 at the same time can affect the blood concentration of felodipine. Enzyme inducers (such as phenytoin, carbamazepine, barbiturates) can cause a decrease in the blood concentration of felodipine. Enzyme inhibitors (cimetidine) can cause an increase in the blood concentration of felodipine. Although felodipine has a high degree of plasma protein binding, it does not affect the binding degree of other plasma protein-bound drugs (such as warfarin).

Ingredients

The main ingredient of this product is felodipine. Its chemical name is 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3-pyridinedicarboxylic acid ethyl ester methyl ester.

Name Description Content CAS NO. Manufacturer
FelodipineIngredients

When taking this product, taking drugs that affect cytochrome P450 at the same time can affect the blood concentration of felodipine. Enzyme inducers (such as phenytoin, carbamazepine, barbiturates) can cause a decrease in the blood concentration of felodipine. Enzyme inhibitors (cimetidine) can cause an increase in the blood concentration of felodipine. Although felodipine has a high degree of plasma protein binding, it does not affect the binding degree of other plasma protein-bound drugs (such as warfarin).

More
86189-69-7 30

Appearance

This product is white tablets.

Indication

Used for the treatment of mild to moderate essential hypertension.

Usage and Dosage

Oral: Starting dose 2.5 mg, twice a day, or as directed by a doctor. The usual maintenance dose is 5 mg or 10 mg per day. If necessary, the dose can be further increased, or other antihypertensive drugs can be added.

Adverse Reactions

This product is the same as other calcium antagonists. Some patients may experience flushing, headache, dizziness, palpitations and fatigue. Most of these reactions are dose-dependent and appear temporarily within a short period of time after the dose is increased, and disappear as the application time increases. This product is the same as other dihydropyridine drugs. It can cause dose-related ankle swelling, gums or periodontitis. Patients may experience mild gum swelling after taking the drug, and may also experience rash and itching.

Precautions

Pregnant women and those who are allergic to this product are prohibited from using it.

Special Population Medication

Precautions for children: There is limited experience with the use of this product in children. Precautions for pregnancy and lactation: Pregnant women are prohibited from using this product. Precautions for the elderly: For patients over 65 years old, the plasma clearance rate of felodipine decreases and the blood concentration increases, so the recommended starting dose is 2.5 mg once a day. These patients should pay attention to monitoring blood pressure when adjusting the dose.

Drug Interactions

1 When taking this product, taking drugs that affect cytochrome P450 at the same time may affect the blood concentration of felodipine. 2 Enzyme inducing drugs (such as phenytoin, carbamazepine, barbiturates) can cause a decrease in the blood concentration of felodipine. 3 Enzyme inhibitors (cimetidine) can cause an increase in the blood concentration of felodipine. Although felodipine has a high degree of plasma protein binding, it does not affect the binding degree of other plasma protein binding drugs (such as warfarin).

Storage

Keep away from light and store in sealed container.

Packaging Specification

10mg

Validity Period

36 months

Manufacturer

Beijing Xiehe Pharmaceutical Co., Ltd.

  • Founded in:

    1981-04-04
  • Address:

    Building 7, No. 37 Yongwang Road, Daxing Biomedicine Industry Base, Zhongguancun Science Park, Daxing District, Beijing
  • Tax NO.:

    91110115101618619W
  • Registered Funds:

    60 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.